Author:
Valle J W,Wasan H,Johnson P,Jones E,Dixon L,Swindell R,Baka S,Maraveyas A,Corrie P,Falk S,Gollins S,Lofts F,Evans L,Meyer T,Anthoney A,Iveson T,Highley M,Osborne R,Bridgewater J
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Agelaki S, Papakostas P, Stathopoulos G, Aravantinos G, Kalbakis K, Sarra E, Souglakos J, Kakolyris S, Kouroussis S, Androulakis N, Vardakis N, Georgoulias V (1999) Phase II study of docetaxel with G-CSF support as first-line treatment for unresectable or advanced biliary tract carcinoma: a multicentre phase II trial. Proc Am Soc Clin Oncol 18: 276a (abstract 1058)
2. Braakhuis BJ, Ruiz van Haperen VW, Welters MJ, Peters GJ (1995) Schedule-dependent therapeutic efficacy of the combination of gemcitabine and cisplatin in head and neck cancer xenografts. Eur J Cancer 31a: 2335–2340
3. Burris III HA, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial [see comments]. J Clin Oncol 15: 2403–2413
4. Casper ES, Green MR, Kelsen DP, Heelan RT, Brown TD, Flombaum CD, Trochanowski B, Tarassoff PG (1994) Phase II trial of gemcitabine (2,2′-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas. Invest New Drugs 12: 29–34
5. Choi CW, Choi IK, Seo JH, Kim BS, Kim JS, Kim CD, Um SH, Kim YH (2000) Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas. Am J Clin Oncol 23: 425–428
Cited by
236 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献